[{"Assets_0_Q3_USD":166394000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-27652000.0,"NetIncomeLoss_3_Q3_USD":-29214000.0,"NetIncomeLoss_1_Q3_USD":-11426000.0,"StockholdersEquity_0_Q3_USD":155028000.0,"Ticker":"YMAB","CIK":"1722964","name":"Y-MABS THERAPEUTICS, INC.","OfficialName":"Y-mAbs Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"556910423.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181113"}]